Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

An Open-Label Extension Study of Combination Therapy With Dimebon and Donepezil in Patients With Alzheimer's Disease

Authors not listed

Medivation, Inc. · 2008

Abstract

The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2008). An Open-Label Extension Study of Combination Therapy With Dimebon and Donepezil in Patients With Alzheimer's Disease. <em>Medivation, Inc.</em>. https://clinicaltrials.gov/study/NCT00704782
Vancouver
Anonymous. An Open-Label Extension Study of Combination Therapy With Dimebon and Donepezil in Patients With Alzheimer's Disease. Medivation, Inc.. 2008.
BibTeX
@misc{anon2008AnOpen, title = {An Open-Label Extension Study of Combination Therapy With Dimebon and Donepezil in Patients With Alzheimer's Disease}, author = {Anonymous}, journal = {Medivation, Inc.}, year = {2008}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings